Thelaughing Halibut

Make Fun Of Business.

Home » Olympus Chosen To Exhibit iTind Machine For BPH Remedy At Vizient Progressive Know-how Change

Olympus Chosen To Exhibit iTind Machine For BPH Remedy At Vizient Progressive Know-how Change

CENTER VALLEY, Pa., Sept. 20, 2021 /PRNewswire/ — Olympus has been chosen to exhibit the iTind system, a quickly implanted system for reduction of enlarged prostate signs, on the Vizient Progressive Know-how Change. Vizient, Inc, the nation’s largest member-driven well being care efficiency enchancment firm, will maintain the Change nearly September 21-23.

The annual Progressive Know-how Change provides chosen suppliers the distinctive alternative to display their applied sciences to provide chain and scientific leaders from Vizient’s member hospitals and material specialists who serve on their provide councils. Every expertise will showcase the way it improves scientific outcomes, enhances security or drives incremental enhancements to well being care supply or enterprise fashions.

Remedy with the iTind system avoids problems related to medication, surgical procedure, or everlasting implants, and it permits males to return to their regular lives shortly after the therapy.i The iTind system works by reshaping the prostate — the system’s three nitinol (nickel titanium alloy) struts regularly develop throughout the 5-7 days the non permanent implant is in place, creating channels via which urine can stream. A U.S. multicenter examine confirmed that the iTind offers fast and efficient reduction of BPH (benign prostatic hyperplasia) signs whereas preserving sexual perform.ii Placement and retrieval will be accomplished in a hospital, ambulatory surgical procedure middle, or medical workplace setting.

“Olympus is thrilled to convey the iTind system to the Vizient Progressive Know-how Change,” mentioned Randy Clark, President of the Olympus Medical Programs Group. “This actually minimally invasive therapy provides urologists and sufferers an extra therapy choice, one which quickly relieves enlarged prostate signs whereas preserving sexual perform. We’re very excited to indicate off the iTind system and its optimistic outcomes as they align with our goal of creating individuals’s lives more healthy, safer and extra fulfilling.”

“Suppliers come to the Change hoping to be awarded an Progressive Know-how contract, which alerts well being care suppliers of their product’s distinctive qualities,” mentioned Debbie Archer, Procurement Compliance Director for Vizient. “We’re happy to incorporate this expertise within the group chosen to take part.”

The annual Progressive Know-how Change is a part of Vizient’s Progressive Know-how Program that features product evaluation of supplier-submitted applied sciences by member-led councils and activity forces. Since 2003, Vizient has obtained over 2,800 expertise submissions as a part of its Progressive Know-how Program.

About Olympus

As a number one medical expertise firm, Olympus makes use of modern capabilities in medical expertise, therapeutic intervention, and precision manufacturing to assist healthcare professionals ship diagnostic, therapeutic, and minimally invasive procedures to enhance scientific outcomes, scale back total prices, and improve the standard of life for sufferers. Olympus’ Medical portfolio consists of endoscopes, laparoscopes, and video imaging methods, in addition to surgical vitality units, system integration options, medical companies, and a variety of EndoTherapy units. For extra data, go to

i Implantation of the iTind system could trigger urinary urgency, pelvic discomfort, dysuria or hematuria. In uncommon circumstances, iTind could trigger urinary tract an infection or acute urinary retention.

ii Chughtai B, Elterman D, Shore N, et al. The iTind Quickly Implanted Nitinol Machine for the Remedy of Decrease Urinary Tract Signs Secondary to Benign Prostatic Hyperplasia: A Multicenter, Randomized, Managed Trial [published online ahead of print, 2020 Dec 26]. Urology. 2020;S0090-4295(20)31520-X. DOI: 10.1016/j.urology.2020.12.022

(PRNewsfoto/Olympus Medical Systems Group)

Cision View unique content material to obtain multimedia:

SOURCE Olympus Medical Programs Group